Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494360 · ClinicalTrials.gov registry record
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 830
- Enrollment target
NCT04494360 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 830 participants.
The verdict
NCT04494360 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 830 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the prevalence of genetic variants associated with liver disease in participants who are known, or are likely to have NAFLD.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2022-10-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04494360
The ClinicalTrials.gov registry entry for NCT04494360 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 830 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04494360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04494360 about?
NCT04494360 is a clinical study titled "Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD". The purpose of this study is to estimate the prevalence of genetic variants associated with liver disease in participants who are known, or are likely to have NAFLD.
What is the current status of trial NCT04494360?
This trial is currently completed. The enrollment target is 830 participants. The study started on 2020-08-07. Estimated completion is 2022-10-10.
What interventions are being tested in trial NCT04494360?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04494360?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.